{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:08:19Z","timestamp":1790536099163,"version":"4.1.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Janssen Pharmaceutical Companies of Johnson & Johnson"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,19]]},"DOI":"10.1093\/rheumatology\/keab461","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T08:16:10Z","timestamp":1622708170000},"page":"iv1-iv3","source":"Crossref","is-referenced-by-count":15,"title":["Interleukin-23 in perspective"],"prefix":"10.1093","volume":"60","author":[{"given":"Jonathan P","family":"Sherlock","sequence":"first","affiliation":[{"name":"Janssen Research & Development, Spring House, PA, USA"},{"name":"Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Cua","sequence":"additional","affiliation":[{"name":"Janssen Research & Development, Spring House, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"2021102007040915600_keab461-B1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"2021102007040915600_keab461-B2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-4-431-54442-5_7","volume-title":"Cytokine frontiers: regulation of immune responses in health and disease","author":"Sherlock","year":"2014"},{"key":"2021102007040915600_keab461-B3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"2021102007040915600_keab461-B4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","article-title":"IL-12 and IL-23: master regulators of innate and adaptive immunity","volume":"202","author":"Langrish","year":"2004","journal-title":"Immunol Rev"},{"key":"2021102007040915600_keab461-B5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135245859900500206","article-title":"Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis","volume":"5","author":"Matusevicius","year":"1999","journal-title":"Mult Scler"},{"key":"2021102007040915600_keab461-B6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1523-1747.1998.00347.x","article-title":"Interleukin-17 and interferon-\u03b3 synergize in the enhancement of proinflammatory cytokine production by human keratinocytes","volume":"111","author":"Teunissen","year":"1998","journal-title":"J Invest Dermatol"},{"key":"2021102007040915600_keab461-B7","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.4049\/jimmunol.165.11.6107","article-title":"Microbial lipopeptides induce the production of IL-17 in Th cells","volume":"165","author":"Infante-Duarte","year":"2000","journal-title":"J Immunol"},{"key":"2021102007040915600_keab461-B8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2021102007040915600_keab461-B9","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1084\/jem.20060244","article-title":"IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis","volume":"203","author":"Chan","year":"2006","journal-title":"J Exp Med"},{"key":"2021102007040915600_keab461-B10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6","volume":"116","author":"Yen","year":"2006","journal-title":"J Clin Invest"},{"key":"2021102007040915600_keab461-B11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4\u2212CD8\u2212 entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"2021102007040915600_keab461-B12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3889\/oamjms.2017.070","article-title":"Ultrasonographic enthesopathy and disease activity in psoriatic arthritis","volume":"5","author":"Ahmed","year":"2017","journal-title":"Open Access Maced J Med Sci"},{"key":"2021102007040915600_keab461-B13","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/ibd\/izy339","article-title":"The prevalence and clinical associations of subclinical sacroiliitis in inflammatory bowel disease","volume":"25","author":"Kelly","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2021102007040915600_keab461-B14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.24389","article-title":"Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis","volume":"60","author":"Ciccia","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021102007040915600_keab461-B15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.38892","article-title":"Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease","volume":"67","author":"Scher","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021102007040915600_keab461-B16","first-page":"1112","article-title":"Bowel inflammation in anterior uveitis and spondyloarthropathy","volume":"22","author":"Ba\u00f1ares","year":"1995","journal-title":"J Rheumatol"},{"key":"2021102007040915600_keab461-B17","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/art.24636","article-title":"Enthesis inflammation in recurrent acute anterior uveitis without spondylarthritis","volume":"60","author":"Mu\u00f1oz-Fern\u00e1ndez","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021102007040915600_keab461-B18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1053\/j.gastro.2018.06.034","article-title":"Diet modifies colonic microbiota and CD4+ T-cell repertoire to induce flares of colitis in mice with myeloid-cell expression of interleukin 23","volume":"155","author":"Chen","year":"2018","journal-title":"Gastroenterology"},{"key":"2021102007040915600_keab461-B19","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/annrheumdis-2020-217309","article-title":"Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression","volume":"79","author":"Watad","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021102007040915600_keab461-B20","author":"Griffiths","year":"2020"},{"key":"2021102007040915600_keab461-B21","first-page":"11","article-title":"The efficacy and safety of guselkumab induction therapy in patients with moderately to severely active Crohn\u2019s disease: week 12 interim analyses from the phase 2 GALAXI 1 study (abstract OP089). Presented at the United European","author":"Sandborn","year":"2020","journal-title":"Gastroenterology Week Virtual Congress"},{"key":"2021102007040915600_keab461-B22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/j.gastro.2019.08.043","article-title":"Efficacy and safety of mirikizumab in a randomized phase 2 study of patients with ulcerative colitis","volume":"158","author":"Sandborn","year":"2020","journal-title":"Gastroenterology"},{"key":"2021102007040915600_keab461-B23","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0140-6736(17)30570-6","article-title":"Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn\u2019s disease: a randomised, double-blind, placebo-controlled phase 2 study","volume":"389","author":"Feagan","year":"2017","journal-title":"Lancet"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/Supplement_4\/iv1\/40739769\/keab461.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/Supplement_4\/iv1\/40739769\/keab461.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T20:08:57Z","timestamp":1634760537000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/Supplement_4\/iv1\/6401926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":23,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2021,10,20]]},"published-print":{"date-parts":[[2021,10,19]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab461","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,10,1]]}}}